Safety of subcutaneous enoxaparin as ancillary therapy in STEMI patients receiving fibrinolysis

David Rott*, David Leibowitz

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1582
Number of pages1
JournalInternational Journal of Cardiology
Volume168
Issue number2
DOIs
StatePublished - 30 Sep 2013
Externally publishedYes

Keywords

  • Alteplase
  • Hemoglobin drop
  • Myocardial infarction

Cite this